Literature DB >> 17505095

A beam source model for scanned proton beams.

Peter Kimstrand1, Erik Traneus, Anders Ahnesjö, Erik Grusell, Bengt Glimelius, Nina Tilly.   

Abstract

A beam source model, i.e. a model for the initial phase space of the beam, for scanned proton beams has been developed. The beam source model is based on parameterized particle sources with characteristics found by fitting towards measured data per individual beam line. A specific aim for this beam source model is to make it applicable to the majority of the various proton beam systems currently available or under development, with the overall purpose to drive dose calculations in proton beam treatment planning. The proton beam phase space is characterized by an energy spectrum, radial and angular distributions and deflections for the non-modulated elementary pencil beam. The beam propagation through the scanning magnets is modelled by applying experimentally determined focal points for each scanning dimension. The radial and angular distribution parameters are deduced from measured two-dimensional fluence distributions of the elementary beam in air. The energy spectrum is extracted from a depth dose distribution for a fixed broad beam scan pattern measured in water. The impact of a multi-slab range shifter for energy modulation is calculated with an own Monte Carlo code taking multiple scattering, energy loss and straggling, non-elastic and elastic nuclear interactions in the slab assembly into account. Measurements for characterization and verification have been performed with the scanning proton beam system at The Svedberg Laboratory in Uppsala. Both in-air fluence patterns and dose points located in a water phantom were used. For verification, dose-in-water was calculated with the Monte Carlo code GEANT 3.21 instead of using a clinical dose engine with approximations of its own. For a set of four individual pencil beams, both with the full energy and range shifted, 96.5% (99.8%) of the tested dose points satisfied the 1%/1 mm (2%/2 mm) gamma criterion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17505095     DOI: 10.1088/0031-9155/52/11/015

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  6 in total

1.  Monte Carlo study of radial energy deposition from primary and secondary particles for narrow and large proton beamlet source models.

Authors:  Christopher R Peeler; Uwe Titt
Journal:  Phys Med Biol       Date:  2012-05-23       Impact factor: 3.609

2.  Golden beam data for proton pencil-beam scanning.

Authors:  Benjamin Clasie; Nicolas Depauw; Maurice Fransen; Carles Gomà; Hamid Reza Panahandeh; Joao Seco; Jacob B Flanz; Hanne M Kooy
Journal:  Phys Med Biol       Date:  2012-02-14       Impact factor: 3.609

3.  Characterizing a proton beam scanning system for Monte Carlo dose calculation in patients.

Authors:  C Grassberger; Anthony Lomax; H Paganetti
Journal:  Phys Med Biol       Date:  2014-12-30       Impact factor: 3.609

4.  Validation of a Monte Carlo Framework for Out-of-Field Dose Calculations in Proton Therapy.

Authors:  Marijke De Saint-Hubert; Nico Verbeek; Christian Bäumer; Johannes Esser; Jörg Wulff; Racell Nabha; Olivier Van Hoey; Jérémie Dabin; Florian Stuckmann; Fabiano Vasi; Stephan Radonic; Guillaume Boissonnat; Uwe Schneider; Miguel Rodriguez; Beate Timmermann; Isabelle Thierry-Chef; Lorenzo Brualla
Journal:  Front Oncol       Date:  2022-06-08       Impact factor: 5.738

5.  Validation and clinical implementation of an accurate Monte Carlo code for pencil beam scanning proton therapy.

Authors:  Sheng Huang; Minglei Kang; Kevin Souris; Christopher Ainsley; Timothy D Solberg; James E McDonough; Charles B Simone; Liyong Lin
Journal:  J Appl Clin Med Phys       Date:  2018-07-30       Impact factor: 2.102

6.  Dose mapping sensitivity to deformable registration uncertainties in fractionated radiotherapy - applied to prostate proton treatments.

Authors:  David Tilly; Nina Tilly; Anders Ahnesjö
Journal:  BMC Med Phys       Date:  2013-06-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.